Pfizer Ltd.
Snapshot View

View in App

Prices View details >>

3870.90 +7.65 ▲0.2%

08 February 2023, 09:08:00 AM
Volume: 23

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pfizerltd.co.in
Market Cap 17,697.28 Cr.
Enterprise Value(EV) 16,137.04 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 134.07 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 28.85 Trailing Twelve Months Ending 2022-09
Industry PE 32.80 Trailing Twelve Months Ending 2022-09
Book Value / Share 637.46 Trailing Twelve Months Ending 2022-09
Price to Book Value 6.07 Calculated using Price: 3,868.45
Dividend Yield 0.90 Period Ending 2022-03
No. of Shares Subscribed 4.57 Cr. 45,747,732 Shares
FaceValue 10
Company Profile
Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products. Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections. The company is taking on some of the world's most difficult diseases, including cancer, arthritis, and osteoporosis.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.20%
1 Week
+1.30%
1 Month
-10.64%
3 Month
-13.45%
6 Month
-7.24%
1 Year
-14.69%
2 Year
-13.85%
5 Year
+70.68%
10 Year
+240.27%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.77 5.31 14.75 14.70 14.11 15.07 15.89 17.19 23.30
Return on Capital Employed (%) 28.96 15.87 22.78 22.62 21.49 23.22 20.38 23.62 29.78
Return on Assets (%) 14.91 4.00 11.22 10.95 10.36 11.25 12.20 13.00 17.24

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 658 1,973 2,164 2,419 2,683 3,011 3,395 2,393 2,864 2,916
Non Curr. Liab. -19 -35 66 62 52 37 136 85 136 85
Curr. Liab. 303 609 658 780 954 892 873 774 853 764
Minority Int.
Equity & Liab. 942 2,547 2,888 3,261 3,690 3,940 4,405 3,252 3,854 3,765
Non Curr. Assets 257 1,295 1,256 1,210 1,273 1,225 1,357 1,344 1,457 1,420
Curr. Assets 686 1,252 1,632 2,051 2,417 2,715 3,048 1,908 2,396 2,345
Misc. Exp. not W/O
Total Assets 942 2,547 2,888 3,261 3,690 3,940 4,405 3,252 3,854 3,765

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1,112 1,853 2,012 1,966 1,969 2,082 2,152 2,239 2,611 2,456
Other Income 109 72 87 101 114 167 184 81 63 78
Total Income 1,221 1,925 2,099 2,067 2,083 2,249 2,336 2,320 2,674 2,534
Total Expenditure -873 -1,474 -1,579 -1,616 -1,468 -1,516 -1,579 -1,526 -1,775 -1,672
PBIDT 349 451 520 451 615 733 757 794 899 862
Interest -1 -2 -1 -2 -1 -2 -11 -15 -11 -13
Depreciation -8 -131 -58 -63 -66 -71 -103 -109 -115 -114
Taxation -119 -138 -165 -180 -188 -231 -133 -171 -160 -174
Exceptional Items -111 10 130 53
PAT 221 70 305 337 360 429 509 498 613 613
Adjusted EPS 74 15 67 74 79 94 111 109 134 134

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -16 132 113 345 329 332 98 323 427 667
Cash Fr. Inv. 626 103 -89 -701 -250 -238 35 1,530 -469 -575
Cash Fr. Finan. -43 -1,360 -1 -62 -83 -110 -110 -164 -1,571 -181
Net Change 567 -1,125 23 -417 -3 -17 23 1,690 -1,613 -88
Cash & Cash Eqvt 1,433 308 488 71 68 51 74 1,764 151 63

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 63.92 63.92 63.92 63.92 63.92 63.92 63.92 63.92 63.92
Public 36.08 36.08 36.08 36.08 36.08 36.08 36.08 36.08 36.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 02 Feb 2023
Board Meeting Intimation
PFIZER LIMITEDhas informed the Exchange about Board Meeting to be held on 09-Feb-2023to inter-alia consider and approve the Unaudited financial results of the Company for the Quarterly ended December 2022 .
Wed, 01 Feb 2023
Board Meeting Intimation
PFIZER LIMITEDhas informed the Exchange about Board Meeting to be held on 09-Feb-2023to inter-alia consider and approve the Unaudited financial results of the Company for the Quarterly ended December 2022 .
Fri, 06 Jan 2023
Certificate under SEBI (Depositories and Participants) Regulations, 2018
In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we furnish herewith Certificate dated January 6, 2023, issued by KFin Technologies Limited, Registrar and Share Transfer Agent of the Company for the quarter ended December 31, 2022.

Technical Scans View Details >>

Tue, 07 Feb 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
CCI Bullish CCI Bullish
RSI Oversold Zone RSI Oversold Zone

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,004.80 -0.2%
Cipla Ltd. 83,244.79 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,450.00 +0.2%
Divi's Laboratories Ltd. 72,982.62 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. 62,084.06 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. 51,953.07 1,536.10 0.0%
Zydus Lifesciences Ltd. 48,525.07 480.15 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-12 31.56 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 480.15 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-12 3.67 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 480.15 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.15 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.15 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.15 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.15 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,004.80 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,035.00 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,450.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,757.95 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,320.00 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,536.10 0.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.15 +0.2%

FAQ's On Pfizer Ltd.

What is Pfizer share price?
Can I buy Pfizer shares now?
What is the Dividend Yield of Pfizer?
What is the Market Cap of Pfizer?
What are the key metrics to analyse Pfizer?
What is the 52 Week High and Low of Pfizer?
What is the trend of Pfizer share price?